Overview

• The Supreme Court's 5-4 decision nullifies Purdue Pharma's $6 billion opioid settlement.
• This ruling changes how Chapter 11 bankruptcy can be used to resolve mass litigation.
• The Sackler family faces potential increased financial liability and ongoing litigation.
• Supporters argue the ruling could lead to larger payouts for victims.
• The decision may prompt new legal strategies in bankruptcy cases.